Functional Phenotypes of Human Vγ9Vδ2 T Cells in Lymphoid Stress Surveillance.
CD161
CD56
GPR56
Vγ9Vδ2 T cells
butyrophilin
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
22 03 2020
22 03 2020
Historique:
received:
14
02
2020
revised:
16
03
2020
accepted:
19
03
2020
entrez:
3
4
2020
pubmed:
3
4
2020
medline:
11
2
2021
Statut:
epublish
Résumé
Butyrophilin and butyrophilin-like proteins select γδ T cells and direct the migration of γδ T cell subsets to distinct anatomical sites. γδ T cells expressing Vδ2 paired with Vγ9 (Vγ9Vδ2 T cells) are the predominant γδ T cell type in human peripheral blood. Vγ9Vδ2 T cells, which cannot be studied easily in vivo because they do not exist in rodents, are often referred to as innate-like T cells. The genetically recombined γδ T cell receptor (TCR) that responds to isoprenoid-derived pyrophosphates (phosphoantigens) produced by infected and malignant cells in a butyrophilin-dependent manner qualifies them as therapeutically relevant components of the adaptive immune system. On the other hand, cell-surface proteins such as the C-type lectin CD161 mark a functional phenotype of Vγ9Vδ2 T cells that mediates TCR-independent innate-like responses. Moreover, CD56 (neural cell adhesion molecule, NCAM) and the G protein-coupled receptor GPR56 define Vγ9Vδ2 T cells with increased cytolytic potential and, like CD161, may also be expressed by dendritic cells, principally facilitating the generation of an innate-like immunological synapse. In this review, we summarise current knowledge of Vγ9Vδ2 T cell functional phenotypes that are critical to lymphoid stress surveillance.
Identifiants
pubmed: 32235722
pii: cells9030772
doi: 10.3390/cells9030772
pmc: PMC7140623
pii:
doi:
Substances chimiques
Receptors, Antigen, T-Cell, gamma-delta
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Références
J Immunol. 2011 Feb 15;186(4):2003-12
pubmed: 21239711
Eur J Immunol. 1989 Sep;19(9):1735-9
pubmed: 2477257
J Immunol. 2012 Apr 1;188(7):2972-6
pubmed: 22393149
Proc Natl Acad Sci U S A. 2017 Aug 29;114(35):E7311-E7320
pubmed: 28807997
Clin Immunol. 2004 Oct;113(1):56-63
pubmed: 15380530
J Exp Med. 2000 May 15;191(10):1777-88
pubmed: 10811870
Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):653-7
pubmed: 1346234
Blood. 2009 Nov 12;114(20):4422-31
pubmed: 19762486
Cell Immunol. 2015 Jul;296(1):31-40
pubmed: 25991474
Cell Rep. 2016 Jul 12;16(2):444-456
pubmed: 27346340
J Immunol. 2005 Dec 15;175(12):7791-5
pubmed: 16339512
J Exp Med. 2003 Jan 20;197(2):163-8
pubmed: 12538656
J Exp Med. 2011 Jul 4;208(7):1511-22
pubmed: 21708931
Blood. 2009 Nov 26;114(23):4823-31
pubmed: 19805616
Cell. 1985 Feb;40(2):259-69
pubmed: 3917858
Front Immunol. 2018 Nov 27;9:2760
pubmed: 30538708
Cell Mol Immunol. 2013 Jan;10(1):35-41
pubmed: 23241899
Cell. 2012 Jan 20;148(1-2):244-58
pubmed: 22265415
PLoS One. 2013;8(1):e51805
pubmed: 23326319
Oncoimmunology. 2014 Nov 14;3(8):e953410
pubmed: 25960933
J Immunol. 2019 Jul 15;203(2):311-320
pubmed: 31285310
Proc Natl Acad Sci U S A. 2015 Feb 10;112(6):E556-65
pubmed: 25617367
Clin Exp Immunol. 2010 Aug;161(2):290-7
pubmed: 20491785
Nat Rev Cancer. 2007 Feb;7(2):79-94
pubmed: 17251915
Blood. 2011 Jul 7;118(1):129-38
pubmed: 21505189
Biochim Biophys Acta. 2013 Jun;1831(6):1009-15
pubmed: 23524243
J Immunol. 1991 Jun 15;146(12):4421-6
pubmed: 1710251
Mol Cell Biol. 2013 Sep;33(18):3644-58
pubmed: 23858057
Hum Immunol. 1997 Dec;58(2):70-82
pubmed: 9475336
Trends Biochem Sci. 2008 Oct;33(10):491-500
pubmed: 18789697
J Exp Med. 1989 Jun 1;169(6):2233-8
pubmed: 2471777
Blood. 2011 Sep 8;118(10):2743-51
pubmed: 21673342
Nat Commun. 2017 Nov 13;8(1):1473
pubmed: 29133794
J Immunol. 2005 Aug 15;175(4):2144-51
pubmed: 16081780
Cell. 2016 Sep 22;167(1):203-218.e17
pubmed: 27641500
Immunol Rev. 2007 Feb;215:59-76
pubmed: 17291279
Immunity. 2014 Apr 17;40(4):490-500
pubmed: 24703779
Trends Pharmacol Sci. 2006 Feb;27(2):92-6
pubmed: 16406086
Eur J Immunol. 2011 Jan;41(1):195-201
pubmed: 21182090
Blood. 2012 Oct 18;120(16):3271-9
pubmed: 22932792
Proc Natl Acad Sci U S A. 2011 Feb 22;108(8):3330-5
pubmed: 21300860
Annu Rev Immunol. 2014;32:121-55
pubmed: 24387714
Immunity. 2009 Aug 21;31(2):184-96
pubmed: 19699170
Nat Immunol. 2018 Dec;19(12):1352-1365
pubmed: 30420626
Int Immunol. 2007 May;19(5):657-73
pubmed: 17446209
Nat Rev Genet. 2010 Jan;11(1):47-59
pubmed: 19997068
Cancer Res. 2010 Dec 1;70(23):9611-20
pubmed: 20947520
Front Cell Dev Biol. 2017 Apr 06;5:34
pubmed: 28428953
Nat Rev Immunol. 2017 Dec;17(12):733-745
pubmed: 28920588
Cell Immunol. 2010;264(1):71-7
pubmed: 20483407
Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):12520-12525
pubmed: 27791087
J Immunol. 2008 Feb 1;180(3):1462-70
pubmed: 18209041
Trends Immunol. 2013 Apr;34(4):151-4
pubmed: 23266231
Clin Cancer Res. 2008 Jul 1;14(13):4232-40
pubmed: 18594005
Front Immunol. 2018 Apr 09;9:486
pubmed: 29686665
Front Immunol. 2018 Jun 26;9:1409
pubmed: 29997614
Cell Rep. 2014 Nov 6;9(3):1075-88
pubmed: 25437561
Immunity. 2020 Mar 17;52(3):487-498.e6
pubmed: 32155411
Nature. 2003 Mar 13;422(6928):164-9
pubmed: 12634786
Immunity. 1997 Jan;6(1):1-11
pubmed: 9052832
Nat Rev Immunol. 2015 Dec;15(12):771-83
pubmed: 26567920
J Biol Chem. 2008 May 23;283(21):14469-78
pubmed: 18378689
Trends Immunol. 2016 Oct;37(10):690-702
pubmed: 27567182
Trends Neurosci. 2017 May;40(5):295-308
pubmed: 28359630
Nat Rev Immunol. 2013 Feb;13(2):88-100
pubmed: 23348415
Immunity. 2019 Nov 19;51(5):813-825.e4
pubmed: 31628053
Immunogenetics. 2014 Apr;66(4):243-54
pubmed: 24526346
J Exp Med. 1991 Jun 1;173(6):1331-8
pubmed: 1827825
Science. 2005 Jul 8;309(5732):264-8
pubmed: 15933162
Nat Immunol. 2008 Feb;9(2):146-54
pubmed: 18176566
Clin Cancer Res. 2012 Jul 1;18(13):3524-31
pubmed: 22529099
Trends Cell Biol. 2009 Sep;19(9):455-64
pubmed: 19716304
Blood. 2012 Sep 13;120(11):2269-79
pubmed: 22767497
Oncoimmunology. 2018 Sep 26;8(1):e1522471
pubmed: 30546961
Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):1039-1044
pubmed: 29339503
J Immunol. 2004 Mar 15;172(6):3573-9
pubmed: 15004158
PLoS One. 2012;7(12):e51851
pubmed: 23284789
J Immunol. 2000 Feb 1;164(3):1148-52
pubmed: 10640724
PLoS One. 2015 Apr 01;10(4):e0123258
pubmed: 25830554
Cancer Res. 2014 Mar 1;74(5):1349-60
pubmed: 24448235
Front Immunol. 2018 Apr 24;9:851
pubmed: 29740448
Annu Rev Immunol. 2000;18:975-1026
pubmed: 10837080
J Immunol. 1994 Sep 15;153(6):2417-28
pubmed: 8077657
Mol Biol Cell. 2004 May;15(5):2375-87
pubmed: 15004227
J Leukoc Biol. 2011 Oct;90(4):735-40
pubmed: 21724806
Front Immunol. 2018 Apr 10;9:658
pubmed: 29692776
Nat Commun. 2017 Jun 05;8:15663
pubmed: 28580927
Blood. 2003 Sep 15;102(6):2310-1
pubmed: 12959943
J Immunol. 2013 Aug 15;191(4):1625-36
pubmed: 23858032